Owen’s RPMGlobal Ltd (ASX: RUL) victory lap
Rask Australia
September 6, 2025
Discover why gold is surging, whether Google remains undervalued, and
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
Discover why gold is surging, whether Google remains undervalued, and
The Australian Investors Podcast: Drew Meredith and Owen Rask cover
The CSL Ltd (ASX: CSL) share price is down 16%
Why WiseTech Global (ASX:WTC) could be the next blue chip
The CSL Ltd (ASX:CSL) share price has risen after the
S&P 500 and Nasdaq rebound 9% and 11% respectively. Australian
The CSL Ltd (ASX:CSL) share price is under the spotlight
The best time to start investing is always now. Whether
Until 45, maximise your debt. After 45, maximise passive income.
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the bestĀ insights.
By downloading, you agree to receive emails from us. You can unsubscribe anytime.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing reportĀ right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Read ourĀ Terms,Ā Financial Services Guide,Ā Privacy Policy. Weāll never sell your email address. Our company is Australian owned.